Trident Texofab Ltd — Important, 14-02-2026: Company Update

Trident Texofab has released its financial results for the quarter and nine-month period ended December 31, 2025. For the quarter, Revenue from Operations stood at ₹25.74 Cr, with Profit After Taxes (PAT) at ₹0.57 Cr, marking a 90% year-on-year growth. For the nine-month period, revenue was ₹84.45 Cr and PAT was ₹3.62 Cr, up 65% year-on-year. The company maintains its focus on manufacturing operations, which contributed 61.8% to revenue, to drive growth and enhance profitability. A recent capital infusion further strengthens its position for future opportunities.